{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-048868","form_type":"8-K","ticker":"AIP","cik":"0001667011","company_name":"Arteris, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.085270+00:00","generated_at":"2026-05-17T00:39:07.481929+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"Arteris Q3 revenue $17.4M (+18% YoY); ACV+royalties $74.9M (+24%); RPO tops $100M","bullets":["Revenue $17.4M (+18% YoY); GAAP operating loss $8.7M vs $7.9M YoY.","Non-GAAP net loss $0.09/sh; positive free cash flow $2.5M (14% of revenue).","ACV+royalties $74.9M (+24% YoY); RPO $104.7M (+34%), first time above $100M.","New license wins: Altera expanded, AMD ordered additional, automotive & aerospace customers.","Provided estimated Q4 and updated FY2025 guidance (specific figures not in release snippet)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-048868","json":"https://secwatch.observer/filing/0001628280-25-048868.json","markdown":"https://secwatch.observer/filing/0001628280-25-048868.md","text":"https://secwatch.observer/filing/0001628280-25-048868.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1667011/000162828025048868/0001628280-25-048868-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1667011/000162828025048868/aip-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:39:07.481929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}